Genetic Signatures (ASX:GSS) Ending Cash Position : A$40.79 Mil (As of Dec. 2024)

View and export this data going back to 2015. Start your Free Trial

What is Genetic Signatures Ending Cash Position?

Genetic Signatures's Ending Cash Position for the quarter that ended in Dec. 2024 was A$40.79 Mil.

Genetic Signatures's quarterly Ending Cash Position increased from Dec. 2023 (A$18.12 Mil) to Jun. 2024 (A$36.25 Mil) and increased from Jun. 2024 (A$36.25 Mil) to Dec. 2024 (A$40.79 Mil).

Genetic Signatures's annual Ending Cash Position declined from Jun. 2022 (A$36.90 Mil) to Jun. 2023 (A$16.35 Mil) but then increased from Jun. 2023 (A$16.35 Mil) to Jun. 2024 (A$36.25 Mil).

Genetic Signatures Ending Cash Position Historical Data

The historical data trend for Genetic Signatures's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genetic Signatures Ending Cash Position Chart

Genetic Signatures Annual Data

Trend

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Jun24

Ending Cash Position

Get a 7-Day Free Trial

31.18

30.12

36.90

16.35

36.25

Genetic Signatures Semi-Annual Data
	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Ending Cash Position	Get a 7-Day Free Trial															26.85	16.35	18.12	36.25	40.79

Genetic Signatures Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Genetic Signatures's Ending Cash Position for the fiscal year that ended in Jun. 2024 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	16.349	+	19.903
	=	36.25

Genetic Signatures's Ending Cash Position for the quarter that ended in Dec. 2024 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	36.252	+	4.541
	=	40.79

Genetic Signatures Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Genetic Signatures's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Genetic Signatures Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Genetic Signatures Ltd (ASX:GSS) » Definitions » Ending Cash Position

Comparable Companies

Traded in Other Exchanges

N/A

Address

7 Eliza Street, Newtown, Sydney, NSW, AUS, 2042

Website

https://www.geneticsignatures.com

Genetic Signatures Ltd is a specialist molecular diagnostics company, specialising in syndromic multiplex real-time PCR testing. The company offers products for the routine detection of infectious diseases and pathogens. It has three operating segments based on regions: Asia Pacific, EMEA, and Americas. It generates the majority of its revenue from the Asia Pacific region. The group's operations are primarily based in Australia, with sales and support teams in the UK, Germany, and the United States.